These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2954566)
21. Purine metabolism enzyme pattern, cytochemical characteristics and clinicopathologic features of CD10-positive childhood T-cell leukemia. Babusíková O; Cáp J; Hrivnáková A; Klobusická M; Mesárosová A; Koníková E Neoplasma; 1991; 38(6):595-602. PubMed ID: 1837333 [TBL] [Abstract][Full Text] [Related]
22. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452 [TBL] [Abstract][Full Text] [Related]
23. The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers. Sobol RE; Mick R; LeBien TW; Ozer H; Minowada J; Anderson K; Ellison RR; Cuttner J; Morrison A; Richards F Leuk Res; 1986; 10(5):481-5. PubMed ID: 2940420 [TBL] [Abstract][Full Text] [Related]
24. Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow. Foot AB; Potter MN; Ropner JE; Wallington TB; Oakhill A J Clin Pathol; 1990 Oct; 43(10):857-9. PubMed ID: 2146287 [TBL] [Abstract][Full Text] [Related]
25. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. Pui CH; Williams DL; Roberson PK; Raimondi SC; Behm FG; Lewis SH; Rivera GK; Kalwinsky DK; Abromowitch M; Crist WM J Clin Oncol; 1988 Jan; 6(1):56-61. PubMed ID: 2961852 [TBL] [Abstract][Full Text] [Related]
26. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. Quackenbush EJ; Letarte M J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538 [TBL] [Abstract][Full Text] [Related]
27. A clinical perspective on cell markers in acute lymphocytic leukemia. Bowman WP; Melvin SL; Aur RJ; Mauer AM Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in acute lymphoid leukaemia of childhood. I. Cytogenetic studies. Szollár J; Révész T; Szakmáry E; Kardos G; Zimonyi I; Schuler D Acta Paediatr Hung; 1986; 27(4):289-93. PubMed ID: 3473995 [TBL] [Abstract][Full Text] [Related]
29. [Heterogeneity of surface characteristics of lymphoid cells altered by malignancy]. Batinić D; Boranić M Lijec Vjesn; 1985 Jul; 107(7):273-7. PubMed ID: 3160902 [No Abstract] [Full Text] [Related]
30. Immunophenotyping of leukaemia: an immunoperoxidase method using air-dried smears. Sandhaus LM; Gajl-Peczalska KJ; Brunning RD Br J Haematol; 1984 Jan; 56(1):131-8. PubMed ID: 6367805 [TBL] [Abstract][Full Text] [Related]
31. Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response. Pullen DJ; Boyett JM; Crist WM; Falletta JM; Roper M; Dowell B; Van Eys J; Jackson JF; Humphrey GB; Metzgar RS Ann N Y Acad Sci; 1984; 428():26-48. PubMed ID: 6234834 [TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia. Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755 [No Abstract] [Full Text] [Related]
33. Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. Greaves M; Delia D; Janossy G; Rapson N; Chessells J; Woods M; Prentice G Leuk Res; 1980; 4(1):15-32. PubMed ID: 6931953 [No Abstract] [Full Text] [Related]
34. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies. Bodner SM; Casavant CH; McHugh TM; Stites DP Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow macrophages and megakaryocytes express common acute lymphoblastic leukaemia antigen. Lai AP; Moss FM; Armitage RJ; Cawley JC Leuk Res; 1985; 9(9):1155-9. PubMed ID: 2933564 [TBL] [Abstract][Full Text] [Related]
36. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992 [TBL] [Abstract][Full Text] [Related]
37. Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission. Self SE; Morgan S; Grush O; La Via MF Hematol Oncol; 1990; 8(2):91-5. PubMed ID: 2140561 [TBL] [Abstract][Full Text] [Related]
38. Cell markers in lymphoma syndrome leukemia in children: a pilot study. Morgan E Med Pediatr Oncol; 1984; 12(1):4-8. PubMed ID: 6700540 [TBL] [Abstract][Full Text] [Related]
39. Expression and modulation of common acute lymphoblastic leukaemia antigen by B prolymphocytic leukaemia cells. de Paoli P; Battistin S; Fantin O; Nimis R; Reitano M; Santini G Immunol Lett; 1985; 9(5):263-6. PubMed ID: 3158600 [TBL] [Abstract][Full Text] [Related]
40. Phenotypic characterization of adult acute lymphoblastic leukaemia: are cytoplasmic immunoglobulins related to prognosis? Raspadori D; Tassinari A; Tazzari PL; Baccarani M Acta Haematol; 1986; 75(3):190-1. PubMed ID: 2944345 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]